Franklin Resources’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$303M Buy
1,753,468
+113,347
+7% +$19.6M 0.08% 238
2025
Q1
$256M Buy
1,640,121
+283,704
+21% +$44.2M 0.07% 252
2024
Q4
$187M Sell
1,356,417
-103,306
-7% -$14.2M 0.05% 314
2024
Q3
$188M Sell
1,459,723
-625,128
-30% -$80.3M 0.05% 312
2024
Q2
$284M Buy
2,084,851
+102,982
+5% +$14M 0.09% 231
2024
Q1
$300M Buy
1,981,869
+917,064
+86% +$139M 0.09% 227
2023
Q4
$134M Sell
1,064,805
-148,480
-12% -$18.7M 0.06% 307
2023
Q3
$114M Sell
1,213,285
-40
-0% -$3.75K 0.06% 331
2023
Q2
$108M Sell
1,213,325
-132,579
-10% -$11.8M 0.05% 349
2023
Q1
$144M Sell
1,345,904
-31,618
-2% -$3.39M 0.07% 304
2022
Q4
$168M Buy
1,377,522
+223,430
+19% +$27.3M 0.09% 267
2022
Q3
$119M Buy
1,154,092
+196,055
+20% +$20.2M 0.06% 339
2022
Q2
$89.1M Buy
958,037
+36,356
+4% +$3.38M 0.04% 408
2022
Q1
$108M Buy
921,681
+2,268
+0.2% +$266K 0.04% 414
2021
Q4
$124M Buy
919,413
+89,702
+11% +$12.1M 0.04% 411
2021
Q3
$132M Buy
829,711
+35,448
+4% +$5.65M 0.05% 384
2021
Q2
$104M Buy
794,263
+61,888
+8% +$8.14M 0.04% 460
2021
Q1
$94.4M Buy
732,375
+312
+0% +$40.2K 0.04% 445
2020
Q4
$122M Buy
732,063
+16,630
+2% +$2.77M 0.05% 368
2020
Q3
$110M Buy
715,433
+17,390
+2% +$2.68M 0.05% 353
2020
Q2
$99.5M Sell
698,043
-2,117
-0.3% -$302K 0.05% 367
2020
Q1
$78.8M Sell
700,160
-118,582
-14% -$13.4M 0.05% 348
2019
Q4
$114M Sell
818,742
-59,492
-7% -$8.28M 0.06% 345
2019
Q3
$84.6M Buy
878,234
+330
+0% +$31.8K 0.05% 403
2019
Q2
$101M Sell
877,904
-283
-0% -$32.6K 0.05% 374
2019
Q1
$103M Buy
878,187
+257,589
+42% +$30.3M 0.06% 349
2018
Q4
$38.9M Buy
620,598
+28,700
+5% +$1.8M 0.02% 541
2018
Q3
$41.9M Buy
591,898
+42,800
+8% +$3.03M 0.02% 587
2018
Q2
$36.5M Buy
549,098
+47,931
+10% +$3.19M 0.02% 610
2018
Q1
$32.8M Buy
+501,167
New +$32.8M 0.02% 650